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Abstract
Background: Well-controlled trophoblast invasion at maternal-fetal interface is a critical event for the normal development
of placenta. CD82 is a member of transmembrane 4 superfamily, which showed important role in inhibiting tumor cell
invasion and migration. We surmised that CD82 are participates in trophoblast differentiation during placenta development.
Methodology/Principal Findings: CD82 was found to be strongly expressed in human first trimester placental villous and
extravillous trophoblast cells as well as in trophoblast cell lines. To investigate whether CD82 plays a role in trophoblast
invasion and migration, we further utilized human villous explants culture model on matrigel and invasion/migration assay
of trophoblast cell line HTR8/SVneo. CD82 siRNA significantly promoted outgrowth of villous explants in vitro (P,0.01), as
well as invasion and migration of HTR8/SVneo cells (P,0.05), whereas the trophoblast proliferation was not affected. The
enhanced effect of CD82 siRNA on invasion and migration of trophoblast cells was found associated with increased
gelatinolytic activities of matrix metalloproteinase MMP9 while over-expression of CD82 markedly decreased trphoblast cell
invasion and migration as well as MMP9 activities.
Conclusions/Significance: These findings suggest that CD82 is an important negative regulator at maternal-fetal interface
during early pregnancy, inhibiting human trophoblast invasion and migration.
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Introduction
The invasion of uterine decidua and maternal vasculature by
trophoblast cells is a critical process for successful establishment
the maternal-fetal circulation and therefore ongoing pregnancy.
During human placental development, three primary types of
trophoblast populations have been identified, cytotrophoblasts
(CTBs), syncytiotrophoblast (STB) and extrovillous trophoblasts
(EVTs), each has a specific role in regulating trophoblst invasion
[1–3]. Trophoblast invasion is characterized by strict spatio-
temporal regulation, which is mediated in an autocrine or
paracrine manner by trophoblastic and uterine factors at the
maternal-fetal interface. For example, EVTs secreting matrix
metalloproteinases (MMPs) are invasive in nature, and play
important role in cell-cell adhesion and migration [4–7], while
tissue inhibitor of MMP (TIMP) inhibits their invasiveness. There
is a complex network of cell types, mediators and signaling
pathways regulating trophoblast invasiveness by different hor-
mones, growth factors, cytokines and chemokines [8–15].
The metastasis suppressor gene CD82 (KAI1) is a member of
the transmembrane 4 protein superfamily (TM4SF). The role of
CD82 in inhibiting cancer progression was discovered during a
genetic screen to identify metastasis suppressor genes [16]. CD82
can form complexes with integrins and other teteaspanins to
regulate intercellular adhesion and transduction and the complex-
es induced intracellular signaling regulating cell proliferation,
activation, and motility [17–20]. To date, the inhibitory role of
CD82 in cancer progression has been well established and related
molecular mechanisms have been intensively studied. Recently, it
was reported that CD82 was expressed at the human maternal-
fetal interface [21] mainly at the decidual compartment [22–24],
while its expression and role in normal trophoblast cells is not
clear. We noticed that two sets of microarray analysis revealed that
CD82 was strongly expressed in the human placenta [25,26].
There is a possibility that CD82 might also express in the
trophoblast cell lineages. And we constantly detected CD82
transcription in several trophoblast cell lines; these clues raised the
possibility that CD82 might also play an uncovered role in the
trophoblastic lineages at the maternal-fetal interface. Based on this
hypothesis, here we investigated the spatio-temporal expression of
CD82 at the human maternal-fetal interface and its effects on
trophoblast cell outgrowth/invasion by using villous explant
culture model as well as trophoblast cell lines.
Results
CD82 Expressed in First Trimester Human Placental
Villous and Invasive Extravillous Trophoblast
To examine the expression pattern of CD82 protein in human
placental villous at different stages of pregnancy, immunohisto-
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protein was intensely stained at cytotrophoblasts and trophoblast
column (TC) (Figure 1A, a). In the maternal compartment of
placenta, staining was seen in decidualized stromal cells in first
trimester (7 w) and early second trimester (15 w) (Figure 1A, c, e).
But there was no staining in invading interstitial EVTs and the
positive staining was very faint in syncytiotrophoblast of anchoring
villous (Figure 1A, e). During the late second trimester (25 w),
CD82 was not detected in villous and weakly expressed in EVTs
(Figure 1A, g). In third trimester (39 w), CD82 was moderately
expressed in cytotrophoblast cells that invaded into the maternal
decidua and was highly expressed in syncytiotrophoblast
(Figure 1A, i). These data showed that CD82 is dynamically
expressed in trophoblast lineages throughout gestation. The
identification of trophoblast cells and stroma cells were confirmed
cytokeratin 7 (CK7) and vimentin staining respectively on a
separate adjacent section (Figure 1A, b, d, f, h, j).
Expression of CD82 in several human trophoblast cell lines was
also examined by RT-PCR, Western blotting and immunofluo-
rescence microscopy. CD82 mRNA could be detected in HTR8/
SVneo and B6Tert (normal trophoblast cell lines), but was very
low in JEG-3 cells (human choriocarcinoma cell lines) (Fig. 1B).
Similarly, CD82 proteins were present in HTR8/SVneo cells and
B6 tert cells, but were also low in JEG-3 cells (Figure 1B).
Immunofluorescence microscopy confirmed and further revealed
that CD82 proteins were present in HTR8/SVneo cells
(Figure 1C).
CD82 siRNA Promoted EVTs Migration of Villous Explants
Given the evident expression of CD82 on TCs in first trimester
placentas, we next investigated whether CD82 have effects on
outgrowth of villous explants on Matrigel. EVT cells migrated
from the cell column tips and infiltrated the matrix between day1
and day3. Explant culture media contained 500 nM stealth siRNA
targeting CD82 and the outgrowth distance of EVTs migration at
the Matrigel surface was measured at 24, 48, and 72 h. At 24 h of
culture, villous explants anchored on Matrigel and outgrowth took
place, but no significant difference was observed between control
siRNA and CD82 siRNA-1,-2 (P.0.05) (Figure 2A, a, b, c). At 48
and 72 h of in vitro culture, CD82 siRNA treated explants
displayed a significant increase in the distance of migration
compared with the control siRNA (48 h, P,0.01;72 h P,0.01)
(Figure 2A, d and e; g, h and i). The successful introduction of
siRNA into the cells of the explant was determined by transfection
with a fluorescent-labeled siRNA which exhibiting universal green
fluorescence (Figure 2B, b).
Knocking-Down CD82 by siRNA Promoted Migration and
Invasion of HTR8/SVneo Cells
The evident expression of CD82 in trophoblast cell lines
suggested a role in controlling trophoblast cell migration and
invasion. Therefore, we further used transwell matrigel invasion
assay and migration assay to test the effects of CD82 siRNA on
HTR8/SVneo cells from first trimester trphoblast cells. siRNA
targeted to CD82 transfected into HTR8/SVneo cells significantly
reduced CD82 expression, the knocking down efficiency were
examined by RT-PCR and western blotting (Figure 3C). The
results showed that HTR8/SVneo cells transfected with CD82
siRNA-1,-2 significantly increased the invasion and migration
ability as compared with control siRNA transfected cells. (P,0.01)
(Figure 3A, B).
Over-Expression of CD82 Inhibited Migration and
Invasion of HTR8/SVneo Cells
To further explore the function of CD82, we over expressed
FLAG-tagged CD82 in the HTR8/SVneo cells. To confirm that
the exogenous protein was expressed properly, we performed
immunocytochemistry using anti-FLAG antibody and observed
that the fusion construct of CD82 was localized to the plasma
membrane (Figure S1). Further more, to make sure the antibody
targeting CD82 is specific, we employed knocking down, over
expression, and immunoprecipitation assay(s) with anti-CD82
and/or anti-FLAG antibodies. (Figure S2). Interestingly, after
CD82 over-expression, an additional band at ,55 KD appeared
(Figure S2, A); we believed that is another form due to different
level of glycosylation. We then examined the effects of exogenous
CD82 on trophoblast cell invasion and migration. As shown in
figure 4C, the exogenous expression of CD82 was examined by
RT-PCR and western blotting. The results showed that HTR8/
SVneo cells overexpressed with CD82 decreased migration and
invasion abilities as compared with control groups. (P,0.05)
(Figure 4A, B).
Up or Down Regulation of CD82 Shows No Obvious
Effects on HTR8/SVneo Cells Proliferation and Apoptosis
To rule out the possibility that the observed invasion/migration
changes were due to effects of CD82 on cell proliferation and/or
viability, we further investigated the effects of CD82 on
trophoblast cell proliferation and apoptosis. HTR8/SVneo cells
transfected with siRNA, or pFLAG-CMV4 plasmids encoding
CD82, were subjected to MTT assay. The effects of CD82 on
trophoblast cell apoptosis were investigated by hoechst 33258
staining. The results showed that either CD82 knock down or over
expression has no obvious effects on the cells proliferation and
apoptosis compared with control groups. (P.0.05, Figure 3D, E;
Figure 4D, E).
Up or Down Regulation of CD82 is Associating with
Altered MMP9 Activity and Expression of TIMP1 and 2
Proteolysis played a crucial role in regulation of cell motility.
Gelatinases (MMP2 and MMP9) have been implicated in
remodeling of extracellular matrix in trophoblast invasion process.
To investigate the effects of CD82 on proteolysis in mediating
trophoblast invasion, MMP2 and MMP9, and their inhibitors
TIMP1 and TIMP2, were examined. Gelatin zymography was
performed to detect the gelatinase MMP2 and MMP9 activity in
HTR8/SVneo cells transfected with CD82 siRNA or overexpres-
sion of CD82. The results revealed that the expression level of
CD82 is negatively related to pro-MMP9 activities and positively
related to the expression level of TIMP1 and 2 (P,0.01)
(Figure 5A, C,). However, the level of pro-MMP2 shows no
significant changes. (P.0.05) (Figure 5A, C,).
Discussion
In the present study, we provided direct evidence that CD82 is
not only expressed in the maternal compartment in the decidua,
but also localized in the trophoblast cell lineage and plays an
important role in inhibiting trophoblast outgrowth and invasion.
Our data demonstrated that CD82 was strongly expressed in the
villous of syncytiotrophoblast, cytotrophoblasts and extravillous
trophoblast cells that invasive into maternal decidua, which is
consistent with the previous microarray data that CD82 is highly
expressed in human placenta [25,26]. Using well-established in
vitro models, we further showed that knocking-down of CD82
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EVT migration through Matrigel, which was associated with the
fact that CD82 suppressed trophoblast invasion and gelatinolytic
activity. Moreover, these findings were consistent when using a
well-defined trophoblast cell line HTR8/SVneo. Our data
demonstrated that CD82 may play an important role in
trophoblast invasion without affecting trophoblast viability/prolif-
eration, possibly by regulating invasion associated proteases in
direct or indirect ways during early pregnancy.
The metastasis suppression role of CD82 is well-defined in
hepatocarcinoma, melanoma, sarcoma, pancreatic and breast
cancer cell lines [27–31], and it has been observed that down
regulation of CD82 mRNA and protein is associated with
advanced stages of many malignancies including prostate, colon,
lung, pancreatic, breast, ovarian and other cancers, suggesting the
loss of CD82 contribute to the increased invasiveness of these
cancers. There are striking similarities between trophoblast cells
and tumor cells with regard to proliferative and invasive properties
[32], and the physiological balance of trophoblast invasiveness is
regulated by cross-talk between trophoblasts and DSCs in a
paracrine and autocrine manner, which involves growth factors,
adhesion molecules, cytokines and chemokines [10,11]. The
potential role of CD82 at maternal-fetal interface in regulating
trophoblast invasion has been studied by other groups [21]. It is
reported that the expression of CD82 in decidual cells at the
human maternal-fetal interface is important in controlling over-
invasion of trophoblast cells in a paracrine manner [21–24].
However, whether CD82 is also expressed in trophoblast lineages
at different stage of gestation remains unclear. Through data
mining from existing microarray database, we interestingly found
Figure 1. Expression of CD82 in human placental villi and cell lines. (A) Immunostaining of CD82 in normal human placental villi in the first
trimester, maternal decidua, second trimester and third trimester. (a) CD82 was strongly expressed in trophoblast columns (TC) and moderate in CTB
of human placental villi during the first trimester. (c) CD82 was highly expressed in decidual cells (DC). (e) CD82 was highly expressed in the maternal
decidua, not detected in EVT and very faint in anchoring villous during the early second trimester. Boxed region is enlarged on the upper panel. (g)
CD82 was absent in villous and very faint in EVT during the late second trimester. (i) CD82 was moderate expressed in cytotrophoblast cells invaded
into the maternal decidua and highly expressed in syncytiotrophoblast in the third trimester. (b, f, h, j) Immunohistochemical staining with anti-
cytokeratin7 (CK7) as a marker of CTB, TC in the first trimester placental vill, EVT in the maternal decidua; (d) Immunohistochemical staining with anti-
vimentin as a maker of decidual cells. (k, l, m, n) negative controls (NEG) on sections in which normal IgG was used in place of primary antibody. CTB:
cytotrophoblast; STB: syncytiotrophoblast; TC: trophoblast column; EVT: extravillous trophoblast; MD: maternal decidua, AV: anchoring villous W:
weeks of pregnancy; Bar represents 100 mm. (B) Expression of CD82 in different trophoblast cell lines determined by semiquantitative RT-PCR and
Western blotting, respectively. GAPDH was used as an internal control for RT-PCR or loading control for Western blotting. HTR8/SVneo: a human
invasive extravillous trophoblast cell line derived from immortalized first trimester trophoblast; B6Tert: immortalized cytotrophoblast cell line; JEG-3:
human choriocarcinoma cell lines. (C) Immunofluorescence of CD82 in HTR8/SVneo cell lines. Fluorescence signals specific to CD82 antibody were
visualized as green, and the nuclei were shown by DAPI staining (blue).
doi:10.1371/journal.pone.0038487.g001
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suggesting a possible contribution from the trophoblast lineage.
Moreover, within our ability to detect two well-established
trophoblast cell lines, HTR8/SVneo and B6 tert, we could
constantly detect strong expression of CD82 at transcription level,
while using two human choriocarcinoma cell lines JEG-3 and
JAR, the CD82 expression is very low or could not be detected
(similarly, an independent group has also shown negative
expression of CD82 in another trophoblast cancer cell line BeWo).
These clues raised the possibility that CD82 might be important in
normal trophoblast cell (cell lines) function while trophoblast
cancer cell (cell lines) has lost CD82 expression. Therefore, in this
study, we further managed to confirm the CD82 expression in
trophoblast cells at both transcription and protein level. Here we
used commercial antibodies from several companies (Abcam,
Santa Cruz, abgent) to examined expression of CD82 at maternal-
fetal interface obtained from first trimester. In contrary to some of
previously published data, 3 out of 4 antibodies (SC-5540/
ab66400/AP6250a) used in our system could detect obvious
expression of CD82 at both maternal decidua and trophoblast
cells, and could also observe evident staining in normal trophoblast
cell lines. These data led us to believe the existence of CD82 in
trophoblastic lineages. Our functional studies by knocking down
and overexpression of CD82 in explant culture and trophoblast
cell line further provided direct evidences to support the role of
CD82 in trophoblast function.
As for the discrepancies obtained compared with other groups
reporting negative expression of CD82 in trophoblast, one
possibility lies in the different timing of sample collection. Since
CD82 expression might have dynamic level and patterns at
different trimesters, it is possible that while in the first trimester
when trophoblast is highly invasive, CD82 was probably required
to inhibit excessive invasion, thus easily to detect. Also, samples
from different individuals under different genetic backgrounds
might contribute to the observed expression variations. Most
possibly and intriguingly, we’ve now known that human CD82
gene showed very diverse splice forms (14 splice forms according
to ensemble database and 10 of them could be transcribed into
different forms of proteins: http://www.ensembl.org/
Homo_sapiens/Gene/
Summary?g=ENSG00000085117;r=11:44585977-44641913).
Moreover, it has been demonstrated that CD82 has more than one
splice forms as demonstrated previously [17]. As each commercial
antibodies only recognize one small epitome of the CD82 protein,
there is a reasonable possibility that the expression discrepancies
revealed by different antibodies might imply that there are
dominant expression of different isoforms of CD82 at trophoblast
and decidual compartments of maternal-fetal interface, which is an
interesting issue warrants further detailed investigations.
As for the downstream signaling and mechanism that respon-
sible for inhibition of CD82 in trophoblast invasion at maternal-
fetal context, it is well-established that trophoblast invasion are
closely correlative with the expression of MMPs [33,34], which are
capable of degrading extracellular matrix to facilitate the invasion
process. This led us to look into the effect of CD82 on MMPs
activities. Among members of MMP family, MMP2 and MMP9
were most extensively studied and was demonstrated to play major
roles in pathways of trophoblast invasion. Indeed, it has been
previously reported that CD82 suppresses tumor invasion by
MMP9 inactivation via TIMP1 up-regulation in carcinoma cell
Figure 2. Silencing of CD82 promote trophoblast outgrowth and migration in villous explant cultures. (A) Villous explants from 5 to 8
weeks of gestation were maintained in culture for 5 days on matrigel under low (3% O2) oxygen tension. Villous explants of CD82 siRNA significantly
increase budding and outgrowth of EVT from the distal end of the villous tips comparing with negative control. Serial pictures of villous explants
were taken under the light microscope after 24, 48, and 72 h of culture in vitro. (B) Villi (a) transfected with FITC-tagged siRNA, showing the
transfection efficiency (b). Villi (c) as a control transfected nothing, showing the villi background fluorescence (d). (C) Three experiments as in B were
quantified by measuring the the migration distance of villous tip relative to CON siRNA transfected for 24 h. (t-test).
doi:10.1371/journal.pone.0038487.g002
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similar mechanisms in control regulated-trophoblast invasion.
In summary, the present data demonstrated that CD82 is
expressed in trophoblast lineages at maternal-fetal interface of first
trimester. CD82 restricts invasion of trophoblast cells, which is
associated with decreased gelatinases. CD82 might be an
important participator in maintaining normal placenta function
and its pathophysiological role in human pregnancy awaits further
investigations.
Figure 3. Silencing of CD82 promoted invasion and migration of HTR8/SVneo cells. (A, B) Representative images of filters containing
invaded cells in Matrigel invasion assay and transwell cell migration assay are shown. The statistical bar graphs show the summary of three
independent experiments. (t-test) (C) Confirmation of RNA interference of CD82 was shown by RT-PCR and Western blotting. GAPDH was used as an
internal control in RT-PCR and a loading control in Western blotting. (D) MTT assay showed no significant difference on proliferation. (t-test) (E) CD82
siRNA-1,-2 had no significant effect on apoptosis of HTR8/SVneo cells. (t-test).
doi:10.1371/journal.pone.0038487.g003
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containing invaded cells in Matrigel invasion assay and transwell cell migration assay are shown. The statistical bar graphs show the summary of three
independent experiments. (t-test) (C) Confirmation of over-expression of CD82 was shown by RT-PCR and Western blotting. GAPDH was used as an
internal control in RT-PCR and a loading control in Western blotting. (D) MTT assay showed no significant difference on proliferation. (t-test) (E)
Overexpression CD82 had no significant effect on apoptosis of HTR8/SVneo cells. (t-test) Mock: pFLAG-CMV4 empty vector, CD82: pFLAG-CMV4-CD82
vector.
doi:10.1371/journal.pone.0038487.g004
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Tissues Collection
Human placental tissues from 5 to 9 weeks (indicated as the
first trimester) were obtained from healthy women undergoing
legal abortion for nonmedical reasons; term placentas were
collected after vaginal delivery or caesarean birth. Ethical
approval was granted by Ethic Committee of the Xuan Wu
Hospital in Beijing. All women were informed and signed
consent to donate placenta for scientific research use. This study
and the use of samples were under standard experimental
protocols approved by the Ethics Committee of the Chongqing
Medical University. All the tissue samples were collected and
stored in ice-cold DMEM (Invitrogen), transported to the
laboratory within 30 minutes after surgery, and washed with ice-
cold PBS before fixation(first trimester=5, normal third
trimester=5).
Cell Culture
The human extravillous trophoblast cell line HTR8/SVneo was
widely used as a model for the first trimester EVT invasion and
migration. HTR8/SVneo cells used in this study were from
Professor Benjamin K Tsang (Department of Obstetrics &
Gynecology and Cellular & Molecular Medicine, University of
Ottawa; Chronic Disease Program, Ottawa Health Research
Institute, Ottawa, ON K1Y 4E9, Canada), as previously
mentioned [36]. Cells were cultured in RPMI 1640(Gibco, MA)
media containing 10% fetal bovine serum (Hyclone, UT), 100IU/
ml penicillin and 100 mg/ml streptomycin, and incubated under
5% CO2 at 37uC. Cells cultured in serum free media for
concentrating supernatants after siRNA transfection.
Semiquantitative RT-PCR
Total RNA was extracted from HTR8/SVneo cells using
TRIzol regent (Invitrogen, CA) and purified as described in the
manufacturer’s instruction. Briefly, after homogenization, chloro-
Figure 5. The effect of CD82 on the activities of MMP2, MMP9 and expression of TIMP1, TIMP2. (A, C) HTR8/SVneo cells were transfected
with CD82 siRNA-1,-2 or pFLAG-CMV4-CD82 plasmid. Total proteins were extracted and western blotting (WB) was performed to detect expression of
CD82. Serum-free culture medium was collected for gelatin zymography assay and for Western blotting assay. CD82 siRNA decreased, while over-
expression CD82 increased protein levels of both TIMP1 and TIMP2. (B, D) Statistical assay of the zymographic results in A or C. CD82 siRNA increased,
while over-expressed CD82 decreased the activity of pro-MMP9. Activity of pro-MMP2 was not significantly affected.
doi:10.1371/journal.pone.0038487.g005
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room temperature and centrifuged for 15 min (12,000 g, 4uC).
The aqueous phase containing the RNA was removed and added
to isopropanol, incubated for 10 minutes at room temperature and
centrifuged for 10 min (12,000 g, 4uC). The supernatant was
removed and the RNA pellet washed in 75% ethanol and
centrifuged for 5 min (7,500 g, 4uC). The supernatant was
removed and the RNA resuspended in DEPC-treated water.
2 mg of RNA were reverse transcribed in a 20 ml reaction
containing Superscript II reverse transcriptase (Invitrogen, CA).
The PCR was conducted in a total volume of 25 ml at different
cycles ranging from 22–30 cycles, determined by PCR amplifica-
tion of the target genes. The GAPDH was employed as an internal
control. PCR proceed for 22–30 cycles (30 sec denaturation at
95uC, 30 sec annealing at 58uC, and 30 sec elongation at 72uC)
after an initial 5 min denaturation step at 95uC. The primers used
in this study include CD82 (Forward: 59-
CTGGGGCTGTACTTTGCTTTC-39, Reverse: 59-CA-
GAAGCCCTTCCTCACAGAA-39) and GAPDH (Forward: 59-
AGCCACATCGCTCAGACA-39, Reverse: 59-TGGACTC-
CACGACGTACT-39) CD82 full-length (Forward: 59-
CCTGCTGCTGTGTGGACGA-39, Reverse: 59-
GCACTGGTTTCGTGGAAGGA-39). Amplifications were ana-
lyzed by electrophoresis on agarose gels containing ethidium
bromide.
Western Blotting
Cells were lysed directly in SDS gel loading buffer (60 mM
Tris–HCl, pH 6.8, 2% SDS, 10% glycerol, 5% beta-mercapto-
ethanol, 0.001% bromphenol blue). Culture media were concen-
trated using Microcon YM-3 centrifugal filter (Millipore Corp.
Bedford). Equal amount of denatured protein per well were
subjected to SDS-PAGE according to standard protocols. Sepa-
rated proteins were transferred electrophoretically onto a nitro-
cellulose membrane (Pall Corporation, Pensacola, FL). After being
blocked with 5% skim milk in TBST for 1 h at room temperature,
the membrane was sequentially incubated with primary antibodies
against CD82 (ab66400, Abcam, Cambridge, UK In-
c.),TIMP1(SC-5538, Santa Cruz, CA), TIMP2 (SC-5539, Santa
Cruz, CA), FLAG (F1804, Sigma-Aldrich, Inc., St. Louis) and
GAPDH (ab37187, Abcam, Cambridge, UK) overnight at 4uC,
and washed three times for 10 min per wash with TBST. A
subsequent incubation with monoclonal HRP-conjugated anti-
body was carried out for 1h at room temperature in 5% skim milk
in TBST, and three times washes with TBST were performed.
Immunoreactive bands were detected using enhanced chemilumi-
nescence (Pierce Chemical Co., Rockford, IL).
Immunohistochemistry
Immunohistochemistry was performed on formalin-fixed, par-
affin-embedded 5 mm sections using the biotin-streptavidin-
peroxidase (SP) and diaminobenzidine (DAB, Zhongshan Golden
Bridge Crop., Beijing, China) kit, as previously reported [21].
Sections were dewaxed in xylene and rehydrated through gradient
of ethanol. Slides were microwaved in citrate buffer (10 mM
citrate sodium, 10 mM citric acid, pH 6.0) or Tris-EDTA buffer
(10 mM Tris, 1mM EDTA, pH 9.0) for 15 min to retrieve
antigen, and then sequentially incubated with 3% hydrogen
peroxide in water for 10 min to quench endogenous peroxidase
activity.
After blocking with normal goat serum for 1 hour, sections were
incubated with primary antibodies against CD82(SC-5540 Santa
Cruz, CA) at 4 ug/ml, vimentin (ab8069, Abcam, Cambridge,
UK) and cytokeratin(CK)7 (ab20206, Abcam) at 5 ug/ml over-
night at 4uC. After washing with PBS, the sections were incubated
with biotinylated secondary antibody followed by streptavidin-
peroxidase, and was detected with DAB solution. Negative control
was performed by replacing the primary antibody with normal
goat serum or IgG from the host species of the primary antibody.
Immunofluorescence
HTR8/SVneo cells or 293FT cells (transfected with FLAG-
tagged CD82 plasmid) were fixed in 4% paraformaldehyde/PBS
for 20 min at room temperature. After fixation, cells were washed
in PBS three times for 15 min and permeabilized with 0.1%
Triton/PBS for 10 min. Cells were incubated in 1% BSA/PBS for
1 hour at room temperature. Then, cells were incubated with anti-
CD82 antibody(ab66400, Abcam) or anti-FLAG(F1804, sigma)
antibody overnight at 4uC followed by fluorescein isothiocyanate
(FITC)-conjugated anti-rabbit or anti-mouse IgG (Zhongsan
Golden Bridge Crop., Beijing, China)at a 1:100 dilution for 1
hour at room temperature. Nuclei were stained with 49,6 9-
Diamidino-2-phenylindole (DAPI) for 3 min. Finally, cells were
viewed under a laser-scanning confocal microscope (Zeiss).
Explant Culture
The explant culture was performed as described previously [13].
In brief, small pieces of tissue (2–3 mm) from tips of first trimester
placental villi (5 w–8 w) were dissected. The samples of dissected
villi were explanted in Millicell-CM culture dish inserts (0.4 mm
pore size, Millipore, Carrigtwohill, Co. Cork, Ireland) precoated
with phenol red-free matrigel substrate (Becton Dickinson, Bed-
ford, MA). Inserts were placed into 24-well culture dishes (Costar,
Cambridge, MA). The explants were cultured in serum-free F12/
DMEM media with 500 nM siRNA, 100IU/ml penicillin and
100 mg/ml streptomycin, at 3% O2/5%CO2/92%N2. EVT
sprouting and migration from the distal end of the villous tips
were recorded daily for up to 4 days. The extent of migration (i.e.
the distance from the cell column base to the tip of the outgrowth)
was measured at defined positions with SPOT Advanced software.
All explants experiments with cultured villi were repeated three
times and were replicated in four separate sets of explants.
RNA Interference (RNAi) and Over-Expression of CD82
HTR8/SVneo cells were transfected with 100 nM CD82
siRNA-1, 2 (1. 59-UAUUUGGUGACUUUGAUACAGGCUG-
39,2 .5 9-AUACAAUAUACACACCCUUGAGGGC-39 Invitro-
gen, MD; Genbank ID for CD82: NM_002231.3), control
siRNA(a universal negative control, Invitrogen, MD) with
Lipofectamine
TM 2000(Invitrogen, MD)as recommended by
manufacturer. The transfection efficiency was more than 90%
by using fluorescent-labeled siRNA.
The full-length CD82 was subcloned into pFLAG-CMV4
vector, and 6 mg were transfected into HTR8/SVneo cells at
70% confluence for 60mm dish. The control was instead with
pFLAG-CMV4 empty vector. The transfection efficiency was
about 40% by counting FLAG positive cells using immunocyto-
chemistry (Figure 1S, A).
Matrigel Invasion Assay
Invasion assay was performed in Matrigel (BD, MA)-coated
transwell inserts (6.5 mm, Costar, Cambridge, UK) containing
polycarbonate filters with 8 mm pores size, as described previously
[37]. Briefly, the inserts were pre-coated with 100 ml of 1 mg/ml
Matrigel matrix at 37uC for 4 h for gelling. 1610
5 HTR8/SVneo
cells in 200 ml serum-free medium were plated in the upper
chamber, whereas medium with 10% fetal bovine serum was
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Matrigel side of the insert were scraped by cotton swab. The
inserts were then fixed in methanol for 10 min at room
temperature and stained with haematoxylin and eosin (Zhongshan
Golden Bridge Corp, Beijing, China). Cells invaded to the other
side of the insert were counted under a light microscope (Olympus
IX51, Japan) in ten random fields at a magnification of6200. The
assay was repeated three times, and the results are represented as
means of invasion percentage (%) 6SD in cell invasion compared
with control. Conditional culture medium was collected for
gelatinolytic activity assay.
Transwell migration assay
The migratory ability of HTR8/SVneo cells was determined by
their ability to cross the 8 mm pores of migration chambers.
Methods used in cell migration assay were similar to Matrigel
invasion assay except that the transwell insert was not coated with
Matrigel.
MTT Assay
After tranfection of siRNA, HTR8/SVneo cells were subjected
to invasion and migration assay, and the remaining cells were
utilized for MTT assay to measure cell proliferation. HTR8/
Svneo cells were seeded at 0.5610
4/well in 96-well. The culture
medium was changed after 20 h to 100 ml MTT reagent (3-[4, 5-
dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide; Apllygen
Corp. Beijing, China). The MTT reagent was gently removed 4 h
later and 100 ml DMSO was added in each well. The optical
density of each well was measured at 570 nm wavelengths
(Beckman DU530, Fullerton, CA). The experiment was performed
in triplicates.
Hoechst 33258 Staining
Hoechst 33258 staining of HTR8/SVneo cells was performed
to evaluate the cell death pattern after treatments of control siRNA
and CD82 siRNA. Twenty-five microliter of cell suspension (about
0.5610
4 cells) was incubated with 33258 (Sigma-Aldrich, Inc., St.
Louis) solution. Cell suspension was placed onto a microscopic
slide covered by a coverslip. The number of apoptotic cells in 200
total cells was counted under a fluorescence microscope micro-
scope (Olympus IX51, Japan) in ten random fields at a
magnification of 6200.
Gelatin Zymography
Analysis of gelatinolytic activity was performed using 10% (w:v)
polyacrylamide gel s containing 0.5 mg/ml gelatin (Difco Labo-
ratories, Detroit, MI) as previously reported [33]. Briefly,
conditioned medium was diluted in 4X non-reducing sample
buffer (8% SDS (w:v), 0.04% bromophenol blue (w:v), 0.25 M
Tris?HCl pH 6.8] and incubated at 37uC for 30 min, and equal
amounts of protein were subjected to substrate-gel electrophoresis.
After electrophoresis, the gel was washed twice in 2.5% Triton X-
100(v:v) in 50 mM Tris–HCl (pH 7.5) for 30 min at room
temperature to remove SDS, and then incubated in calcium assay
buffer (50 mM Tris, 10 mM CaCl2, 1 mM ZnCl2,1 %
Triton62100, pH 7.5) for 24 h at 37uC. Gels were stained with
Coomassie Brilliant Blue R250 in 50% methanol and 10% acetic
acid and destained in 10% acetic acid to reveal zones of gelatinase
activity.
Statistical Analysis
Each experiment was performed in triplicates. The bands from
RT-PCR, Western blotting and gelatin zymography were
quantified by MetaView Image Analyzing System (Version 4.50;
Universal Imaging Corp., Downingtown, PA). Results were
presented as means6SD. Statistical analyses include one-way
ANOVA and t-test which were performed using the Statistical
Package for Social Science Science (SPSS for Windows package
release 10.0; SPSS Inc., Chicago, IL) and indicated in Results and
figure legends. P,0.05 was considered as statistically significant.
Supporting Information
Figure S1 Transfection efficiency and expression pat-
tern of the pFLAG-CMV4-CD82 plasmid in HTR8/SVneo
and 293FT cell lines. (A) Immunocytochemistry was performed
by using Flag antibody (visualized as green signal) in CD82 over-
expressed HTR8/SVneo cells. The nuclei were shown by DAPI
staining (blue). The green signals indicate that the efficiency of
transfection is more than 30%, and FLAG-CD82 fusion protein
localizes to the plasma membrane properly. (B) We use 293FT
cells to further confirm the results. Bar represents 100 mm.
(TIF)
Figure S2 CD82 antibody evaluation/validation (A)
CD82 knockdown and over-expression assay in HTR8/SVneo
cells. Antibody anti-CD82 was used. The arrow indicates two
specific bands in over-expression assay. GAPDH were used as
loading control. Line 1: HTR8/SVneo cells transfected with
control siRNA Line 2–4: HTR8/SVneo cells transfected with
CD82 siRNA-1,-2,-3. Line 5: HTR8/SVneo cells with transfec-
tion reagent only Line 6: HTR8/SVneo cells transfected with 3 mg
pFLAG-CMV4 empty vector Line 7: HTR8/SVneo cells
transfected with 3 mg pFLAG-CMV4-CD82 plasmid Line 8:
HTR8/SVneo cells transfected with 2 mg pFLAG-CMV4 empty
vector Line 9: HTR8/SVneo cells transfected with 2 mg pFLAG-
CMV4-CD82 plasmid (B) CD82 over-expressed HTR8/SVneo
cells, whole cell lysates and proteins immunoprecipitated using
FLAG-beads. Line 1, 4: Whole cell lysates of CD82 over-expressed
HTR8/SVneo cells Line 2, 3: Immunoprecipitated proteins using
Flag beads from CD82 over-expressed HTR8/SVneo cell lysates.
(TIF)
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